PaTHway CHINA TRIAL: A Trial to Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

NCT05387070 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoparathyroidism
Parathyroid Hormone Deficiency
Endocrine System Diseases
Parathyroid Diseases

Interventions

DRUG: TransCon PTH
DRUG: placebo

Sponsor

Visen Pharmaceuticals (Shanghai) Co., Ltd.